Going from evidence to recommendations. BMJ 2008; 336: 1049 1051. 446. The AGREE Collaboration. Development and validation of an interna- tional appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003; 12: 18 23. 447. Shiffman RN, Shekelle P, Overhage JM et al. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann Intern Med 2003; 139: 493 498. 448. Institute of Medicine. Finding What Works in Health Care: Standards for Systematic Reviews. The National Academies Press: Washington, DC, 2011. 449. Institute of Medicine. Clinical Practice Guidelines We Can Trust. The National Academies Press: Washington, DC, 2011. 450. Siebenhofer A, Plank J, Horvath K et al. Angiotensin receptor blockers as anti-hypertensive treatment for patients with diabetes mellitus: meta- analysis of controlled double-blind randomized trials. Diabet Med 2004; 21: 18 25. 451. Casas JP, Chua W, Loukogeorgakis S et al. Effect of inhibitors of the renin- angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005; 366: 2026 2033. 452. Ogihara T, Kikuchi K, Matsuoka H et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3 107. 453. American Diabetes Association. Standards of medical care in diabetes 2012. Diabetes Care 2012; 35 (Suppl 1): S11 S63. references